Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Nongken Alkaloid Factory (also known as Gansu State Farms Medical Alkaloids Factory Co., Ltd.) is a state-owned pharmaceutical enterprise based in Lanzhou, Gansu Province, China. Established in 1996, it operates as a wholly-owned subsidiary of Gansu State Farms Group Co., Ltd. and is the sole designated enterprise in China authorized to produce raw materials for opiate anesthetic drugs. The company focuses on the specialized market of anesthetic and analgesic raw materials, active pharmaceutical ingredients (APIs), and derivative pharmaceutical intermediates. Its core product portfolio includes concentrate of poppy straw (CPS), thebaine, morphine base, oxycodone hydrochloride, naloxone hydrochloride, and traditional Chinese medicine plant extracts such as licorice extract. Operating under strict national directive plans, the company maintains advanced manufacturing facilities compliant with China GMP standards to ensure the safe and stable supply of critical medical materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Nongken Alkaloid Factory.